The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits-Reference-Cited by-同舟云学术

The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits

Published:1991-05 Issue:1 Volume:103 Page:1013-1018
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Daugherty Alan,Zweifel Ben S.,Schonfeld Gustav

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.1991.tb12293.x/fullpdf

Reference39 articles.

1. Presence of a modified low density lipoprotein in humans;AVOGARO;Arteriosclerosis,1988

2. Concentration-dependent antioxidant activity of probucol in low density lipoproteins in vitro: probucol degradation precedes lipoprotein oxidation;BARNHART;J. Lipid Res.,1989

3. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit;BOYD;Am. J. Pathol.,1989

4. Probucol. A reappraisal of its pharmacological properties and therapeutic uses in hypercholesterolemia;BUCKLEY;Drugs,1989

5. Cellular pathology of progressive atherosclerosis in the WHHL rabbit;BUJA;Arteriosclerosis,1983

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatoprotective Activity of Poly-herbal Formulation against paracetamol Intoxicated Wistar-albino rats;Research Journal of Pharmacy and Technology;2024-07-24

2. Research progress on the therapeutic effects of nanoparticles loaded with drugs against atherosclerosis;Cardiovascular Drugs and Therapy;2023-05-13

3. Highly sensitive H2O2-scavenging nano-bionic system for precise treatment of atherosclerosis;Acta Pharmaceutica Sinica B;2023-01

4. Red blood cell biomimetic nanoparticle with anti-inflammatory, anti-oxidative and hypolipidemia effect ameliorated atherosclerosis therapy;Nanomedicine: Nanotechnology, Biology and Medicine;2022-04

5. Hyperlipidemic Rabbit Models for Anti-Atherosclerotic Drug Development;Applied Sciences;2020-12-04